Q: In this task, you are given a text of many news articles seperated by special token "|||||". Your task is to summarize them.
Breaking News Emails Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings. 
  
 / Updated By Mike Brunker 
  
 The company that created the Lumosity “brain training” program has agreed to pay $2 million to settle Federal Trade Commission charges that it deceived consumers into believing that its mind games could help users excel at work and school and reduce or delay “cognitive impairment associated with age and other serious health conditions.” 
  
 Under the settlement announced Tuesday, Lumos Labs, the company that developed Lumosity, will make redress payments to customers and provide them with an easy way to cancel auto-renewal billing for the service, which included both online and mobile app subscriptions from monthly payments of $14.95 to lifetime memberships for $299.95. 
  
 “Lumosity preyed on consumers’ fears about age-related cognitive decline, suggesting their games could stave off memory loss, dementia, and even Alzheimer’s disease,” Jessica Rich, director of the FTC’s Bureau of Consumer Protection, said in a news release announcing the settlement. “But Lumosity simply did not have the science to back up its ads.” 
  
 According to the FTC’s complaint, Lumosity offered 40 games that it said target and train specific areas of the brain. The company advertised that training for 10 to 15 minutes three or four times a week could help users achieve their “full potential in every aspect of life.” 
  
 Truth in Advertising? Alleged Auto Thief Arrested in 'I Do Dumb Things' T-Shirt 
  
 Lumosity marketed its service through TV commercials, mails, blog posts, social media and used Google AdWords to drive traffic to its Lumosity.com website, purchasing hundreds of keywords related to memory, cognition, dementia, and Alzheimer’s disease, according to the complaint. 
  
 It also failed to disclose that some testimonials on the website were solicited through contests that promised substantial prizes, including a round trip to San Francisco, where the company is based. ||||| Lumosity, which created a brain game powerhouse by telling people it could make them smarter, is paying for its lies. Lumos Labs will pay the Federal Trade Commission $2 million for deceptive trade practices. 
  
  
  
 “Lumosity preyed on consumers’ fears about age-related cognitive decline, suggesting their games could stave off memory loss, dementia, and even Alzheimer’s disease,” FTC Bureau of Consumer Protection Director Jessica Rich said in a statement. “But Lumosity simply did not have the science to back up its ads.” 
  
 Advertisement 
  
 People who signed up for Lumosity’s auto-renewal program between January 1, 2009 and December 31, 2014 will get notified about the FTC action and given an easy way to cancel. 
  
 Art by Jim Cooke ||||| WASHINGTON (Reuters) - Online game provider Lumosity has agreed to pay $2 million to settle allegations that it made unfounded claims that its games reduce or delay intellectual impairment that comes with age, the Federal Trade Commission said on Tuesday. 
  
 Lumosity had advertised that its suite of games, which it sells through subscription apps, could also help students learn better and improve athletic performance, the FTC said. 
  
 “Lumosity preyed on consumers’ fears about age-related cognitive decline, suggesting their games could stave off memory loss, dementia, and even Alzheimer’s disease,” said Jessica Rich, director of the FTC’s Bureau of Consumer Protection. “Lumosity simply did not have the science to back up its ads.” 
  
 The apps, which were advertised on National Public Radio, CNN, Fox News, Pandora and others, cost $14.95 per month, the agency said. 
  
 Lumosity, a unit of Lumos Labs, said the settlement will allow the company to move on, and said the FTC’s complaint was “a reflection of marketing language that has been discontinued.” 
  
 The $2 million paid by Lumosity will be used to refund consumers, the FTC said. 
  
 The San Francisco-based company, which was formed in 2005, has 70 million users in 182 countries, the company says on its web site. 
  
 The company was also criticized by the FTC for failing to disclose that it had given prizes, including a trip to San Francisco, for consumers who gave testimonials for the product, the FTC said. |||||
A:
Vitaminwater isn't actually a health drink, Almond Breeze might not actually have many almonds in it, and Lumosity may not actually protect your brain from cognitive impairment. The so-called "brain training" company, which offers users online and mobile app subscriptions for the use of its "cognitive games," will pay $2 million to settle Federal Trade Commission charges that it deceived customers, NBC News reports. "Lumosity preyed on consumers' fears about age-related cognitive decline, suggesting their games could stave off memory loss, dementia, and even Alzheimer's disease," an FTC rep says in a news release. "But Lumosity simply did not have the science to back up its ads." The settlement will include redress payments made to customers. Lumosity advertised on NPR, CNN, and Fox News, among other places, Reuters reports. Lumosity told users that by playing its games for 10 to 15 minutes, three or four times per week, they could achieve their "full potential in every aspect of life." (Sample headline about this recent development: "Lumosity Has to Pay $2 Million for Lying About Its Bullshit Brain Games.") A review of the Lumosity website on Tuesday finds that it appears to have shifted its focus; the company now says it's "exploring new ways to understand human cognition" and doing "in-house research explores many topics, from brain training to how sleep and mood interact with our training program." As for what users get, expectations have been downgraded a bit to simply the opportunity to "challenge their brains." Lumosity also failed to disclose the fact that it solicited some of the testimonials featured on its website via contests that offered big prizes. Lumosity says in a statement that the settlement relates only to "marketing language that has been discontinued," and not to the quality of the product it offers.